Skip to main content

Table 5 Sleep diary data

From: Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

 

PEA

Placebo

Baseline

Week 4

Week 8

Baseline

Week 4

Week 8

Sleep time (hrs)

6.1 ± 1.5

6.7 ± 1.4

6.7 ± 1.3

6.1 ± 1.5

6.5 ± 1.3

6.5 ± 1.5

Sleep Latencya (min)

42.8 ± 42.2

26.8 ± 26.3*

23.4 ± 23.1*

36.2 ± 40.5

34.2 ± 40.5

30.3 ± 39.2

Interruptions (n)

3.3 ± 2.1

3.0 ± 2.3

3.3 ± 3.0

3.9 ± 3.8

3.0 ± 3.0

2.9 ± 2.8

Interruptions (min)

41.0 ± 39.3

29.9 ± 30.1

35.0 ± 34.8

35.3 ± 32.0

31.6 ± 41.5

32.6 ± 42.7

  1. N.B. Data presented as mean ± standard deviation; * = significant difference between groups; a sleep latency data for participants reporting > 10 min at baseline (n = 78); PEA Palmitoylethanolamide
Back to article page

Sleep Science and Practice

ISSN: 2398-2683

Contact us